Since inflammation has emerged as an integrative factor for cardiovascular disease, many studies used biochemical inflammatory biomarkers such as cytokines (IL-6, TNF-α), cell adhesion molecules (P-selectin) and acute-phase reactants (CRP, fibrinogen) as surrogate parameters for cardiovascular risks [15]. The gene discussed is CRP; the disease is cardiovascular disorder.